TC
ADPT icon

Tejara Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Tejara Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-909,061
Closed -$3.29M – 57
2024
Q2 		$3.29M Buy
909,061
+640,047
+238% +$2.03M 1.2% 30
2024
Q1 		$864K Buy
+269,014
New +$1.04M 0.32% 54

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Tejara Capital's ADPT Position: Q3 2024 in Review

Tejara Capital sold out of Adaptive Biotechnologies (ADPT) in Q3 2024, closing a stake of 909,061 shares — an estimated $3.29M sold.

Tejara Capital first reported a position in ADPT in Q1 2024 and held it in 2 quarters. The position peaked at $3.29M in Q2 2024. 187 funds tracked by Wall St. Rank hold ADPT as of Q3 2024.

  • Tejara Capital reported no remaining Adaptive Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Tejara Capital sold 909,061 Adaptive Biotechnologies shares in Q3 2024, an estimated $3.29M.
  • Tejara Capital first reported a position in Adaptive Biotechnologies in Q1 2024 and held it in 2 quarters.
  • Tejara Capital's Adaptive Biotechnologies position peaked at $3.29M in Q2 2024.
  • 187 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2024.

Based on Tejara Capital's 13F filing for Q3 2024, filed 13 Nov 2024.